Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Breast Cancer Research and Treatment|March 30, 2011
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancerC K Lee, M Hudson, M Stockler, et al.British Journal of Cancer|August 19, 2004
Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literatureJ Vardy, K Engelhardt, K Cox, et al.Critical Reviews in Oncology/Hematology|April 7, 2009
Levels of sex hormones have limited effect on cognition in older men with or without prostate cancerS M H Alibhai, S Mahmoud, F Hussain, et al.British Journal of Cancer|January 26, 2012
Survival gains needed to offset persistent adverse treatment effects in localised prostate cancerM T King, R Viney, D P Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC A Townsley, K Chi, D S Ernst, et al.British Journal of Cancer|May 30, 2018
Author Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.British Journal of Cancer|June 28, 2017
Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.British Journal of Cancer|September 6, 2006
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotideJ Cebon, M Findlay, C Hargreaves, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trialP Grimison, A Mersiades, A Kirby, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2009
Third consensus on medical treatment of metastatic breast cancerS Beslija, J Bonneterre, H J Burstein, et al.Pageof 7